The upgraded autonomous electric aircraft, featuring a carbon fiber airframe, is authorized for commercial operations in the ...

USA Compression Partners hosted its Fourth Quarter 2024 Earnings Conference Call, providing a comprehensive update on the ...

An essential item to include on your Hawaii packing list is a portable charger. For a three-in-one option, Raycon's Magic Pad ...

Compression socks (or compression stockings) gently squeeze the legs, helping push blood from the legs to the heart. They can also help manage and ease swelling associated with certain health ...

The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

Brianna is a contributing writer for InStyle covering all things beauty. She is known for discovering the coolest niche beauty brands from around the world, really good hair day tips, and best-in ...

The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...

The two ruled Wilson-Spray’s death was a homicide that was caused by compression of the neck. Thiersch determined a significant hemorrhage found within the soft tissue of her throat indicated ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...